ArticleFrontiers in pharmacology2022

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction

Jing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.